ERNESTO LAJARA: Open Payments
NPI 1083183859 · SOUTH MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 25 payments from 5 companies in 2025. Trend: 2023 $635 · 2024 $171 · 2025 $717
Food & beverage: $717
| Company | Payments | Amount |
|---|---|---|
| Luye Pharma (USA) Ltd. | 2 | $252 |
| Teva Pharmaceuticals USA, Inc. | 14 | $193 |
| E.R. Squibb & Sons, L.L.C. | 2 | $143 |
| Neurocrine BioSciences, Inc. | 6 | $107 |
| Axsome Therapeutics, Inc. | 1 | $22 |
Products named: ERZOFRI EXTENDED-RELEASE, COBENFY, UZEDY, INGREZZA, AUSTEDO XR, Auvelity.
Industry payments across FL — which companies pay providers there.
